Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 12 pseudogene 1 (SMIM12P1) is a **pseudogene** derived from a gene that encodes a small integral membrane protein. Pseudogenes such as SMIM12P1 do not produce functional proteins, typically due to mutations that prevent transcription or translation, loss of regulatory elements, or integration as non-functional processed pseudogenes[1][3]. While pseudogenes were historically thought to be "junk" DNA, research indicates some can play regulatory roles at the RNA level, for example by acting as microRNA decoys or through the generation of small interfering RNAs, but there is no specific evidence supporting such a role for SMIM12P1[3]. This gene is not considered a therapeutic target, does not encode a receptor, enzyme, or functional protein, and no drugs target it[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 12 pseudogene 1 (SMIM12P1).